文献速递流行病学与生物统计

无症状与症状前SARS-CoV-2感染的发生及传播潜力:一项动态系统综述与Meta分析的更新

Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
PubMed 文献 · PLoS Med · 2022-05-26

该动态系统综述更新检索至2021年7月6日,纳入130项研究。基于接触或暴发调查的46项研究中无症状比例汇总为19%(95%CI 15%至25%)。无症状感染接触者的续发感染率相对于有症状感染为0.32(95%CI 0.16至0.64)。13项建模研究显示症状前个体的传播比例高于无症状个体。

要点

  • 基于接触或暴发调查的46项研究中,无症状感染汇总比例为19%(95%CI 15%至25%)。
  • 无症状感染接触者的续发感染率相对于有症状感染为0.32(95%CI 0.16至0.64,8项研究)。
  • 13项建模研究中,症状前个体的SARS-CoV-2传播比例高于无症状个体。

核心结论

  • 基于截至2021年7月发表的研究,大多数SARS-CoV-2感染并非持续无症状,无症状感染的传染性低于有症状感染。
  • 当研究间变异极大时Meta分析的汇总估计可能产生误导,应呈现预测区间。
  • 未来研究应确定担忧变异株所致及疫苗接种或既往感染后免疫人群中SARS-CoV-2感染的无症状比例。
  • 若无采用减少选择偏倚和测量偏倚方法的前瞻性纵向研究,以本动态系统综述所纳入研究类型进行的进一步更新不太可能提供可靠的SARS-CoV-2无症状感染比例汇总估计。

研究设计与样本

  • 本研究为动态系统综述与Meta分析更新,方案于2020年4月1日首次发布、2021年6月18日最后更新。
  • 检索PubMed、Embase、bioRxiv和medRxiv,最近一次检索为2021年7月6日。
  • 纳入记录PCR诊断SARS-CoV-2者随访开始与结束时症状状态的研究,或数学建模研究;排除仅限已诊断者、单个个体或家庭、随访不充分的研究。
  • 由一名评价者提取数据、第二名评价者核实,分歧通过讨论或第三名评价者解决;实证研究采用专门清单评估偏倚风险,建模研究采用已发表清单评估。
  • 所有数据合成采用随机效应模型;共纳入130项研究。

主要发现

  • 因异质性高,未估计总体无症状感染的平均比例(四分位距14%至50%,预测区间2%至90%),也未估计基于定义人群筛查的84项研究的平均比例(四分位距20%至65%,预测区间4%至94%)。
  • 基于接触或暴发调查的46项研究中,无症状汇总比例为19%(95%CI 15%至25%,预测区间2%至70%)。
  • 无症状感染接触者相对于有症状感染接触者的续发感染率为0.32(95%CI 0.16至0.64,预测区间0.11至0.95,8项研究)。
  • 13项拟合数据的建模研究中,症状前个体所致的SARS-CoV-2传播比例高于无症状个体。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据的局限性包括高异质性以及非为测量持续无症状感染而设计的研究中存在高选择偏倚和信息偏倚风险。
  • 关于担忧变异株或已接种疫苗人群的信息有限。
  • 当研究间变异极大时Meta分析的汇总估计可能产生误导,应呈现预测区间。
  • 若无采用减少选择偏倚和测量偏倚方法的前瞻性纵向研究,进一步更新不太可能提供可靠的SARS-CoV-2无症状感染比例汇总估计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Debate about the level of asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection continues. The amount of evidence is increasing and study designs have changed over time. We updated a living systematic review to address 3 questions: (1) Among people who become infected with SARS-CoV-2, what proportion does not experience symptoms at all during their infection? (2) What is the infectiousness of asymptomatic and presymptomatic, compared with symptomatic, SARS-CoV-2 infection? (3) What proportion of SARS-CoV-2 transmission in a population is accounted for by people who are asymptomatic or presymptomatic? METHODS AND FINDINGS: The protocol was first published on 1 April 2020 and last updated on 18 June 2021. We searched PubMed, Embase, bioRxiv, and medRxiv, aggregated in a database of SARS-CoV-2 literature, most recently on 6 July 2021. Studies of people with PCR-diagnosed SARS-CoV-2, which documented symptom status at the beginning and end of follow-up, or mathematical modelling studies were included. Studies restricted to people already diagnosed, of single individuals or families, or without sufficient follow-up were excluded. One reviewer extracted data and a second verified the extraction, with disagreement resolved by discussion or a third reviewer. Risk of bias in empirical studies was assessed with a bespoke checklist and modelling studies with a published checklist. All data syntheses were done using random effects models. Review question (1): We included 130 studies. Heterogeneity was high so we did not estimate a mean proportion of asymptomatic infections overall (interquartile range (IQR) 14% to 50%, prediction interval 2% to 90%), or in 84 studies based on screening of defined populations (IQR 20% to 65%, prediction interval 4% to 94%). In 46 studies based on contact or outbreak investigations, the summary proportion asymptomatic was 19% (95% confidence interval (CI) 15% to 25%, prediction interval 2% to 70%). (2) The secondary attack rate in contacts of people with asymptomatic infection compared with symptomatic infection was 0.32 (95% CI 0.16 to 0.64, prediction interval 0.11 to 0.95, 8 studies). (3) In 13 modelling studies fit to data, the proportion of all SARS-CoV-2 transmission from presymptomatic individuals was higher than from asymptomatic individuals. Limitations of the evidence include high heterogeneity and high risks of selection and information bias in studies that were not designed to measure persistently asymptomatic infection, and limited information about variants of concern or in people who have been vaccinated. CONCLUSIONS: Based on studies published up to July 2021, most SARS-CoV-2 infections were not persistently asymptomatic, and asymptomatic infections were less infectious than symptomatic infections. Summary estimates from meta-analysis may be misleading when variability between studies is extreme and prediction intervals should be presented. Future studies should determine the asymptomatic proportion of SARS-CoV-2 infections caused by variants of concern and in people with immunity following vaccination or previous infection. Without prospective longitudinal studies with methods that minimise selection and measurement biases, further updates with the study types included in this living systematic review are unlikely to be able to provide a reliable summary estimate of the proportion of asymptomatic infections caused by SARS-CoV-2. REVIEW PROTOCOL: Open Science Framework (https://osf.io/9ewys/).

来源:PLoS Med,查看原文。版权归原作者所有。

引用

  1. Buitrago-Garcia D, Ipekci AM, Heron L, et al. Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis. PLoS Med. 2022. PMID: 35617363. doi:10.1371/journal.pmed.1003987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。